-
AstraZeneca China’s Western Headquarters was officially opened to facilitate the development of a healthy ecological integration in the Western Region
Time of Update: 2021-10-10
"Lai Minglong, General Manager of AstraZeneca China, gave an opening speech at the sub-forum of "New Development and New Ideas for Internet Hospitals"Take root in the west and deepen China's commitmentAstraZeneca’s Western China Headquarters, which was grandly unveiled at this summit, is located in the Frontier Medical Center of Chengdu High-tech Zone.
-
Stroke: Atrial fibrillation, which can predict the progress of indicators of cerebral small blood vessels
Time of Update: 2021-09-03
Therefore, this population-based cohort study aims to investigate the longitudinal association between atrial fibrillation and multiple brain SVD markers in elderly people living in the community .
The magnetic resonance imaging markers of SVD include perivascular space, lacune and white matter hyperplasia volume (WMH), lateral ventricle and total brain tissue .
-
The pharmacy has been intensively rectified by Chinese medicine doctors for half a year
Time of Update: 2021-08-08
Focus on the four aspects of rectification This time, the Chongqing regulatory authorities will focus on the following four aspects: First, check whether the pharmaceutical retail companies that provide traditional Chinese medicine services have obtained the qualifications in accordance with the law, and whether the scope of the medical services provided is consistent with the approved and registered diagnosis and treatment subjects or filing The scope of diagnosis and treatment is the same .
-
The shape of nanoparticles in body fluids may help identify the type of cancer
Time of Update: 2021-08-03
A recent study by scientists at Nihon University has shown that the shape of "extracellular vesicles" (ev), derived from cells in body fluids, can be used as a biomarker to identify cancer types .
-
[Live preview] First aid "new speed"-rapid diagnosis and treatment of dangerous upper gastrointestinal bleeding
Time of Update: 2021-08-02
Therefore, Metz Medical specially invited Professor [Lin Zhihui], director of the Department of Gastroenterology, Fujian Provincial Hospital, to give online lectures to share clinical experience with everyone.
Emergency diagnosis and treatment process for dangerous upper gastrointestinal bleeding4.
-
Announcement of the State Food and Drug Administration on the conversion of Jinzhen Granules and Fuke Baifeng Capsules to OTC (No. 3 of 2021
Time of Update: 2021-07-07
The contents of the non-prescription drug inserts other than those specified in the template inserts shall be implemented in accordance with the original approval documents .
Templates for non-prescription drug instructions State Food and Drug Administration January 7, 2021 Announcement No.
-
JAMA Netw Open: Chinese scholars: secondhand smoke exposure will increase children's ADHD risk
Time of Update: 2021-06-21
pixabaypixabayRecently, a study published in the JAMA Network Open magazine showed that second-hand smoke exposure from pregnancy to childhood is closely related to the appearance of ADHD symptoms in school-age children , especially in the prenatal and early postnatal periods .
-
The latest setting of the national consumables centralized procurement policy, orthopedic joints are mixed
Time of Update: 2021-06-16
"One product, one policy" procurement ideas, explore the national procurement of orthopedic joints In the document, it is mentioned that according to the characteristics of the clinical use of high-value medical consumables, the degree of standardization, the number of participating companies and other factors, policies can be implemented in accordance with their aptitude, and procurement can be carried out by means of bidding, competitive negotiation, and inquiry .
-
Countdown 100 days to the 6th Guangzhou International Biotechnology Conference and Exhibition
Time of Update: 2021-06-08
In order to enrich the participation experience of exhibitors and professional visitors, and strengthen the stickiness with the organizing committee, the organizer of the BTE Guangzhou International Biotechnology Conference specially organized the "Registration and Visiting Lottery Draw" and "Check-in and Appreciation Activities" on the 100-day countdown to the exhibition.
-
Immunotherapy reduces the risk of recurrence of lung cancer
Time of Update: 2021-06-02
On May 20, Roche announced that its blockbuster PD-L1 inhibitor Tecentriq, as an adjuvant therapy, has achieved positive results in a pivotal phase 3 clinical trial for the treatment of early stage NSCLC patients.
-
Shanghai passed local legislation: Chinese medicine is included in public health emergency management system
Time of Update: 2021-04-27
Encourage pharmaceutical manufacturers, operators of Chinese medicinal materials and Chinese medicinal pieces, medical institutions, and industry associations to establish an information traceability system in accordance with relevant laws, regulations and technical standards.
-
Secondary analysis of the RACECA study: Can patients with acute large vessel occlusion with RACE ≥ 5 be directly transferred to an endovascular treatment center for treatment? 丨ISC2021
Time of Update: 2021-03-27
Yimaitong compiled from: Secondary Analysis of the Racecat Trial: Benefit of Direct Transfer to an Endovascular Stroke Center According to the Presence of Large Vessel Occlusion and the Transfer Time to the Endovascular Center.
-
Alzheimer's Dementia: China-Sweden joint study: Higher education can cushion the impact of middle-aged depression on dementia
Time of Update: 2021-03-21
In this way, Wenzhe Yang and others of Tianjin Medical University explored:(1) Investigate the association between depression and dementia risk from the perspective of life course (2) Assess whether genetic and early family factors can explain this association (3) Explore the moderating role of education in the depression-dementia association.
-
Chi-Med began submitting Surufatinib's application to the FDA for the treatment of advanced neuroendocrine tumors
Time of Update: 2021-01-02
(Chi-Med) today announced that it has begun filing with the U.S. Food and Drug Administration (FDA) a new drug application (NDA) for Surufatinib's treatment of pancreatic and non-pancreatic neuroendocrine tumors.
NDA is based on two positive Phase III studies in China and from patients with non-pancreatic and pancreatic neuroendocrine tumors in the United States.
-
The study found that recessive transmission is the main mode of human-to-human transmission of the new coronavirus
Time of Update: 2020-11-29
authors say that because asymptomatic infections are difficult to track and various omissions may occur during the isolation period, the study's estimates of the recessive spread of the new coronavirus tend to be conservative, and the actual risk of recessive transmission is likely to be greater.
